Continuous Monitoring of Alcohol Use by Wearable Biosensors -- SBIR Fast-Track Award
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This contract is a Small Business Innovation Research Fast-Track award issued by the National Institutes of Health to Giner, Inc. for the development of next-generation wearable continuous alcohol monitoring technology. Valued at 2,499,714 dollars under a firm fixed price structure, the project focuses on creating a discreet enzymatic biosensor capable of measuring blood alcohol concentration in real time from interstitial fluid. The scope includes a Phase I study to validate the sensor technology and algorithms, followed by a Phase II study to optimize the probe and develop a lightweight prototype suitable for research and commercialization. The current period of performance is expected to end on August 31, 2026, with a high confidence level that the requirement will be a full recompete. The opportunity is designated as a total small business set-aside and will be conducted via full and open competition after exclusion of sources. Managed by the Department of Health and Human Services, the work is performed in Auburndale, Massachusetts, and falls under the classification of research and development in the field of biosensors.
General Info
Place of Performance
Auburndale, MA, 024661311, USASet-Aside
Documents
0AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Current Contract: 75N94020C00005 Incumbent: GINER, INC. Contract Value: $2,499,714 Potential End Date: 2026-08-31T00:00:00.000Z Competition: FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES Pricing: FIRM FIXED PRICE Classification: full-recompete (Confidence: high - 90/100)
The research under this contract is toward the development of next-generation, wearable continuous alcohol monitoring (CAM) technology designed to measure, record, and store Blood Alcohol Concentration (BAC) in real time. This SBIR - Fast-Track-type contract contains a base contract requirement for an SBIR Phase I Study and a contract option for an SBIR Phase II Study. This SBIR contract is awarded under NIAAA Topic Area 018, "Alcohol Biosensor Development for Continuous Alcohol Consumption Monitoring", contained in SBIR Solicitation PHS 2020-1. The SBIR Phase I Study (base contract requirement) will perform analysis toward validating the technology of a new, discreet, wearable, stable, selective and highly sensitive enzymatic biosensor and algorithms that can detect alcohol in real-time and directly from interstitial fluid and evaluate its concentration in a mixture similar to human serum. The SBIR Phase II Study (contract option) will further refine and optimize the performance of the sensor probe and integrate it into a compact, lightweight prototype device ready to use in research studies that will effectively demonstrate its potential to private investors to support commercialization.
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Health And Human Services → National Institutes Of Health Nichd
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
